Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1834-1843, doi:10.1016/j.jacc.2008.08.027 (Published online 17 September 2008).
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Appendix
Right arrow View Related Genuine Article on CVN
Right arrow View Cardiosource Journal Scan
Right arrow All Versions of this Article:
j.jacc.2008.08.027v1
j.jacc.2008.08.027v2
52/23/1834    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linde, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linde, C.
Related Collections
Right arrowRelated Articles

EXPEDITED PUBLICATION: CARDIAC RESYNCHRONIZATION

Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

Cecilia Linde, MD, PhD*,*, William T. Abraham, MD, FACC{dagger}, Michael R. Gold, MD, PhD{ddagger}, Martin St. John Sutton, MD§, Stefano Ghio, MD, Claude Daubert, MD|| REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group

* Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
{dagger} Division of Cardiovascular Medicine and the Davis Heart and Lung Research Institute, Ohio State University, Columbus, Ohio
{ddagger} Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina
§ University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
Policlinico San Matteo, Pavia, Italy
|| Département de Cardiologie, CHU, Rennes, France

Manuscript received June 13, 2008; revised manuscript received July 31, 2008, accepted August 14, 2008.

* Reprint requests and correspondence: Dr. Cecilia Linde, Department of Cardiology, Karolinska University Hospital, S-17176 Stockholm, Sweden (Email: cecilia.linde{at}ki.se).

Objectives: We sought to determine the effects of cardiac resynchronization therapy (CRT) in New York Heart Association (NYHA) functional class II heart failure (HF) and NYHA functional class I (American College of Cardiology/American Heart Association stage C) patients with previous HF symptoms.

Background: Cardiac resynchronization therapy improves left ventricular (LV) structure and function and clinical outcomes in NYHA functional class III and IV HF with prolonged QRS.

Methods: Six hundred ten patients with NYHA functional class I or II heart failure with a QRS ≥120 ms and a LV ejection fraction ≤40% received a CRT device (±defibrillator) and were randomly assigned to active CRT (CRT-ON; n = 419) or control (CRT-OFF; n = 191) for 12 months. The primary end point was the HF clinical composite response, which scores patients as improved, unchanged, or worsened. The prospectively powered secondary end point was LV end-systolic volume index. Hospitalization for worsening HF was evaluated in a prospective secondary analysis of health care use.

Results: The HF clinical composite response end point, which compared only the percent worsened, indicated 16% worsened in CRT-ON compared with 21% in CRT-OFF (p = 0.10). Patients assigned to CRT-ON experienced a greater improvement in LV end-systolic volume index (–18.4 ± 29.5 ml/m2 vs. –1.3 ± 23.4 ml/m2, p < 0.0001) and other measures of LV remodeling. Time-to-first HF hospitalization was significantly delayed in CRT-ON (hazard ratio: 0.47, p = 0.03).

Conclusions: The REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) trial demonstrates that CRT, in combination with optimal medical therapy (±defibrillator), reduces the risk for heart failure hospitalization and improves ventricular structure and function in NYHA functional class II and NYHA functional class I (American College of Cardiology/American Heart Association stage C) patients with previous HF symptoms. (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction [REVERSE]; NCT00271154 [ClinicalTrials.gov] ).

Key Words: cardiac resynchronization therapy • heart failure • randomized controlled trial • biventricular pacing • reverse remodeling

Abbreviations and Acronyms
  AEAC = Adverse Event Advisory/Endpoint Committee
  CRT = cardiac resynchronization therapy
  HF = heart failure
  ICD = implantable cardioverter-defibrillator
  LV = left ventricular
  LVESVI = left ventricular end-systolic volume index
  NYHA = New York Heart Association


Related Articles

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?
Christophe Leclercq, Philippe Mabo, and Jean Noel Trochu
J. Am. Coll. Cardiol. 2008 52: 1844-1846. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A40. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur J Heart FailHome page
D. J. van Veldhuisen, A. H. Maass, S. G. Priori, P. Stolt, I. C. van Gelder, K. Dickstein, and K. Swedberg
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
Eur J Heart Fail, December 1, 2009; 11(12): 1143 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. G.F. Cleland, A. P. Coletta, A. Yassin, L. Buga, A. Torabi, and A. L. Clark
Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT
Eur J Heart Fail, December 1, 2009; 11(12): 1214 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Daubert, M. R. Gold, W. T. Abraham, S. Ghio, C. Hassager, G. Goode, T. Szili-Torok, C. Linde, and on behalf of the REVERSE Study Group
Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial
J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1837 - 1846.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Exner
Is it Time to Expand the Use of Cardiac Resynchronization Therapy to Patients With Mildly Symptomatic Heart Failure?
J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1847 - 1849.
[Full Text] [PDF]


Home page
CirculationHome page
M. St. John Sutton, S. Ghio, T. Plappert, L. Tavazzi, L. Scelsi, C. Daubert, W. T. Abraham, M. R. Gold, C. Hassager, J. M. Herre, et al.
Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure
Circulation, November 10, 2009; 120(19): 1858 - 1865.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. S. Francis and W.H. Wilson Tang
Early Cardiac Resynchronization Therapy and Reverse Remodeling in Patients With Mild Heart Failure: Is It Time?
Circulation, November 10, 2009; 120(19): 1845 - 1846.
[Full Text] [PDF]


Home page
Eur Heart JHome page
G. Breithardt
MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
Eur. Heart J., November 1, 2009; 30(21): 2551 - 2553.
[Full Text] [PDF]


Home page
EuropaceHome page
J. C. Daubert, C. Leclercq, and P. Mabo
Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
Europace, November 1, 2009; 11(suppl_5): v87 - v92.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Linde
Cardiac resynchronization therapy in mild heart failure
Europace, November 1, 2009; 11(suppl_5): v72 - v76.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Dickstein, N. Bogale, S. Priori, A. Auricchio, J. G. Cleland, A. Gitt, T. Limbourg, C. Linde, D. J. van Veldhuisen, J. Brugada, et al.
The European cardiac resynchronization therapy survey
Eur. Heart J., October 2, 2009; 30(20): 2450 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Steffel and D. Hurlimann
Current practice of cardiac resynchronization therapy (CRT) in the real world: insights from the European CRT survey
Eur. Heart J., October 2, 2009; 30(20): 2433 - 2435.
[Full Text] [PDF]


Home page
NEJMHome page
M. Jessup
MADIT-CRT -- Breathtaking or Time to Catch Our Breath?
N. Engl. J. Med., October 1, 2009; 361(14): 1394 - 1396.
[Full Text] [PDF]


Home page
NEJMHome page
A. J. Moss, W. J. Hall, D. S. Cannom, H. Klein, M. W. Brown, J. P. Daubert, N.A. M. Estes III, E. Foster, H. Greenberg, S. L. Higgins, et al.
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
N. Engl. J. Med., October 1, 2009; 361(14): 1329 - 1338.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. Marcus, E. Keung, and M. M. Scheinman
The year in review of clinical cardiac electrophysiology.
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 777 - 787.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. Mont, E. Guasch, and A. Berruezo
An implantable defibrillator and what else?
Eur. Heart J., July 1, 2009; 30(13): 1551 - 1553.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Osswald, B. Schaer, M. Kuhne, and C. Sticherling
No benefit from cardiac resynchronization therapy in asymptomatic patients.
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2198 - 2198.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Linde, W. T. Abraham, M. R. Gold, M. S. J. Sutton, S. Ghio, C. Daubert, and REVERSE Study Group
Reply.
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2198 - 2199.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. G.F. Cleland, A. P. Coletta, A. L. Clark, and D. Cullington
Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA
Eur J Heart Fail, June 1, 2009; 11(6): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Malik
Precise electrocardiographic measurements and clinical sense
Europace, May 1, 2009; 11(5): 550 - 553.
[Full Text] [PDF]


Home page
BMJHome page
R. M Cubbon and K. K A Witte
Cardiac resynchronisation therapy for chronic heart failure and conduction delay
BMJ, April 28, 2009; 338(apr28_2): b1265 - b1265.
[Full Text]


Home page
Circ Heart FailHome page
J. G.F. Cleland and D. Cullington
Digoxin: Quo Vadis?
Circ Heart Fail, March 1, 2009; 2(2): 81 - 85.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
The CRT Survey Scientific Committee
European cardiac resynchronization therapy survey: rationale and design
Eur J Heart Fail, March 1, 2009; 11(3): 326 - 330.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
Is Cardiac Resynchronization Therapy Beneficial in Milder Heart Failure?
Journal Watch (General), January 13, 2009; 2009(113): 4 - 4.
[Full Text]


Home page
ESC Textbook of Cardiovascular MedicineHome page
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner
CHAPTER 23 Heart Failure
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Leclercq, P. Mabo, and J. N. Trochu
Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1844 - 1846.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement